SA
NHI icon

Shilanski & Associates’s National Health Investors NHI Stock Holding History

Shilanski & Associates’s Portfolio NHI Stock Details NHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-52,480
Closed -$2.72M – 103
2023
Q3 		$2.72M Buy
52,480
+1,442
+3% +$75.4K 1.11% 32
2023
Q2 		$2.7M Buy
51,038
+829
+2% +$42.7K 1.09% 34
2023
Q1 		$2.51M Buy
50,209
+970
+2% +$52.9K 1.13% 34
2022
Q4 		$2.59M Buy
+49,239
New +$2.7M 1.13% 34
2022
Q3 		– Sell
-45,682
Closed -$2.77M – 191
2022
Q2 		$2.77M Buy
45,682
+1,299
+3% +$73.9K 1.29% 33
2022
Q1 		$2.64M Sell
44,383
-416
-0.9% -$23.7K 1.11% 35
2021
Q4 		$2.59M Buy
44,799
+484
+1% +$26.8K 1.1% 37
2021
Q3 		$2.39M Buy
44,315
+5,144
+13% +$321K 1.11% 36
2021
Q2 		$2.64M Buy
39,171
+1,016
+3% +$70.8K 1.25% 31
2021
Q1 		$2.76M Buy
38,155
+583
+2% +$40.7K 1.47% 29
2020
Q4 		$2.6M Buy
+37,572
New +$2.39M 1.58% 26

Other funds holding NHI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Shilanski & Associates's NHI Position: Q4 2023 in Review

Shilanski & Associates sold out of National Health Investors (NHI) in Q4 2023, closing a stake of 52,480 shares — an estimated $2.72M sold.

Shilanski & Associates first reported a position in NHI in Q4 2020 and held it in 11 quarters. The position peaked at $2.77M in Q2 2022. 211 funds tracked by Wall St. Rank hold NHI as of Q4 2023.

  • Shilanski & Associates reported no remaining National Health Investors position as of Q4 2023 after selling out during the quarter.
  • Shilanski & Associates sold 52,480 National Health Investors shares in Q4 2023, an estimated $2.72M.
  • Shilanski & Associates first reported a position in National Health Investors in Q4 2020 and held it in 11 quarters.
  • Shilanski & Associates's National Health Investors position peaked at $2.77M in Q2 2022.
  • 211 funds tracked by Wall St. Rank held National Health Investors as of Q4 2023.

Based on Shilanski & Associates's 13F filing for Q4 2023, filed 10 Jan 2024.